Intramuscular gentamicin improves the efficacy of ciprofloxacin as an antibiotic prophylaxis for transrectal prostate biopsy

Annals of the Academy of Medicine Singapore

Volumn 38, Issue 3, 2009, Pages 212-216

  Ho, Henry S S ^a   Ng, Lay Guat ^a   Tan, Yeh Hong ^a   Yeo, Mavis ^a   Cheng, Christopher W S ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Antibiotics; Infection; Prophylaxis; Prostate biopsy

Indexed keywords

ANTIBIOTIC AGENT; CEFEPIME; CEFTRIAXONE; CIPROFLOXACIN; GENTAMICIN;

ADD ON THERAPY; ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIOLOGY; BACTERIUM ISOLATION; BLOOD CULTURE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ESCHERICHIA COLI; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; INTERVENTION STUDY; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PROSTATE BIOPSY; RETROSPECTIVE STUDY; SEPSIS; TRANSRECTAL ULTRASONOGRAPHY;

EID: 64549151596     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Raaijmaker R, Kirkels WJ, Roobol MJ, Wildhagen MF, Schrder FH. Complication rate and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology 2002;60:826-30.
2. Gilad J, Borer A, Maimon N, Riesenberg K, Klein M, Schlaeffer F. Failure of ciprofloxacin prophylaxis for ultrasound guided transrectal prostatic biopsy in the era of multiresistant enterobacteriaceae. J Urol 1999;161:222.
3. Kapoor DA, Klimberg IW, Malek GH, Weganke JD, Cox CE, Patterson AL, et al. Single dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology 1998;52:552-8.
4. Shigemura K, Tanaka K, Yasuda M, Ishihara S, Muratani T, Deguchi T, et al. Efficacy of 1-day prophylaxis medication with fluoroquinolone for prostate biopsy. World J Urol 2005;23:356-60.
5. Aron M, Rajeev TP, Gupta NP. Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study. BJU Int 2000;85:682-5.
6. Matsumoto T, Kiyota H, Matsukawa M, Yasuda M, Arakawa S, Monden K, et al. Japanese guidelines for prevention of perioperative infections in urological field. Int J Urol 2007;14:890-909.
7. Shandera KC, Thiabault GP, Deshon GE, Jr. Variability in patient preparation for prostate biopsy among American urologist. Urology 1998;52:644-6.
8. Binsaleh S, Al-Assiri M, Aronson S, Steinberg A. Septic shock after transrectal ultrasound guided prostate biopsy. Is ciprofloxacin prophylaxis always protecting? Can J Urol 2004;11:2352-3.
9. Sheikh M, Hussein AYT, Kehinde EO, Al-Saeed O, Rad AB, Ali YM, et al. Patient's tolerance and early complications of transrectal sonographically guided prostate biopsy: prospective study of 300 patients. J Clin Ultrasound 2005;33: 452-6.
10. Png JCD, Tan E, Foo KT. A comparative study of the distribution of ofloxacin and ciprofloxacin in prostatic tissues after simultaneous oral ingestion. BJU 1997;79:781-4.
11. Tal R, Livine PM, Lask DM, Baniel J. Empirical management of urinary tract infections complicating transrectal ultrasound guided prostate biopsy. J Urol 2003;169,1762-5.
12. Lindert KA, Kabalin JN, Terris MK. Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy. J Urol 2000;164:76-80.
13. Rodriguez LV, Terris MK. Risk and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of literature. J Urol 1998;160:2115-20.
14. Santucci R, Krieger JN. Gentamicin for the practicing urologist: review of efficacy, single daily dosing and "switch" therapy. J Urol 2000; 163:1076-84.
15. Cormio L, Beradi B, Callea A, Fiorentino N, Sblendorio D, Zizzi V, et al. Antimicrobial prophylaxis for transrectal prostate biopsy: a prospective study of ciprofloxacin vs piperacillin/tazobactum. BJU Int 2002;90: 700-2.
16. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound directed transrectal core biopsy of the prostate. J Urol 1989;142:71-3.
17. Griffith BC, Morey AF, Ali-khan MA, Canby-Hagino E, Foley JP, Rozanski TA. Single dose levofloxacin prophylaxis in patients at low risk. J Urol 2002;168:1021-3.